SITC Clinical Immuno-Oncology Network (SCION) commentary on measurement and interpretation of essential biomarkers in early clinical trials

Affiliations

Carlo Bifulco: 2 0000 0004 0456 863Xgrid.240531.1Earle A. Chiles Research Institute, Robert W. Franz Cancer Research CenterProvidence Portland Medical Center Portland OR USA
Holden T Maecker: Institute for Immunity, Transplantation and Infection, Stanford University, Stanford, CA, USA
Leslie Cope: Aff1 0000 0001 2171 9311grid.21107.35Bloomberg-Kimmel Institute for Cancer ImmunotherapyJohns Hopkins University Baltimore MD USA
Tricia Cottrell: 2Queen’s University, Kingston, ON, Canada
Sacha Gnjatic: Department of Hematology and Medical Oncology, Mount Sinai School of Medicine, New York, New York, USA
Michael T Lotze: Aff1 grid.21925.3d0000000419369000University of Pittsburgh Pittsburgh PA USA
Laura Chow: 1Fate Therapeutics, Inc., San Diego, CA, USA
Joe Yeong Poh Shen: 8 Division of Pathology, Singapore General Hospital, Singapore

Abstract

Abstract

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com